Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy

The goal of this study is to demonstrate the efficacy of an evidence-based, small-group, telehealth intervention ('STRIDE') for improving patients' ability to cope with side effects from adjuvant endocrine therapy (AET) and adhere to AET medication regimens for patients with hormone-sensitive breast cancer.

NCT Number	NCT07759947
Lead Sponsor	Massachusetts General Hospital Collaborators: National Cancer Institute (NCI)
Conditions	Hormone Receptor Positive Breast Cancer
Enrollment	400 participants
Start Date	2027-02-01
Primary Completion	2030-01-01 (estimated)
Study Completion	2031-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-12